Top Markets
#1 Black Phoenix Black Phoenix +860.33%
#2 QuantixAI QuantixAI +102.43%
#3 Nesa Nesa +40.53%
#4 MetaDAO MetaDAO +26.53%
#5 Pons Pons +25.86%
#6 LayerZero LayerZero +19.60%
#7 Bedrock Bedrock +18.18%
#8 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +17.02%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +14.96%
#10 SPX6900 SPX6900 +14.67%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Avidity Biosciences Inc Avidity Biosciences Inc

Avidity Biosciences Inc

RNAM
Rank in Stocks #2179
Avidity Biosciences, Inc. is at the forefront of developing a novel class of... Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
Share Price
$71.34
Last synced: 2026-03-03
Market Cap
$9.84B
Change (1 day)
0.00%
Change (1 year)
-
Country
US
Trade Avidity Biosciences Inc (RNAM)

Category

Healthcare
Number of shares outstanding for Avidity Biosciences Inc (RNAM)
Number of shares outstanding as of August 2026: 0
According to Avidity Biosciences Inc latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Avidity Biosciences Inc (RNAM) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH